Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-12
2010-10-26
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S340000, C548S248000, C546S272100
Reexamination Certificate
active
07820705
ABSTRACT:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR.
REFERENCES:
patent: 2088996 (1937-08-01), Hoffer
patent: 3466296 (1969-09-01), Piemmons
patent: 3562286 (1971-02-01), Bramhall et al.
patent: 6005116 (1999-12-01), Kojima et al.
patent: 2003/0225158 (2003-12-01), Auerbach et al.
patent: 3247454 (1984-06-01), None
patent: 0378111 (1990-07-01), None
patent: 0573883 (1993-12-01), None
patent: 1224568 (1971-05-01), None
patent: 0116116 (2001-03-01), None
patent: 2004024939 (2004-03-01), None
patent: 2005033103 (2005-04-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Selkoe, Physiological Reviews, vol. 81(2), 2001, p. 760.
Findeis, Pharmacology & Therapeutics 2007, 116, 266-286.
Epple et al. Bioorganic & Medicinal Chemistry Letters 2006, 16, 4376-4380.
Epple et al. Bioorganic & Medicinal Chemistry Letters 2006, 16, 5488-5492.
Yadav, et al., “Zinc Promoted Mild and Efficient Method for the Esterification of Acid Chlorides with Alcohols”, Synthetic Communications, 1998, pp. 2337-2342, vol. 28, issue 13.
Yedidia, et al., “Regioselectivity in cycloaddition reactions on solid phases”, Can J. Chem., 1980, pp. 1144-1150, vol. 58.
Micetich, “Studies in Isoxazole Chemistry, I. 3- or 5-(5-Nitro-2furyl)-5 or -3-methylisoxazoles”, J. Med. Chem., 1969, pp. 611-616, vol. 12, No. 4.
Azimioara Mihai
Epple Robert
Russo Ross
Xie Yongping
Anderson Rebecca L
Coughlin Matthew P
IRM LLC
Reid Scott W.
The Genomics Institute of the Novartis Research Foundation
LandOfFree
Compounds and compositions as PPAR modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and compositions as PPAR modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as PPAR modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201206